Jeil Pharma Holdings Inc (KRX: 002620)

Jeil Pharma Holdings Revenue

Jeil Pharma Holdings had revenue of 197.03B KRW in the quarter ending June 30, 2024, a decrease of -1.16%. This brings the company's revenue in the last twelve months to 783.56B, down -0.94% year-over-year. In the year 2023, Jeil Pharma Holdings had annual revenue of 804.04B with 1.40% growth.

• Revenue (ttm): 783.56B
• Revenue Growth: -0.94%
• P/S Ratio: 0.16
• Revenue / Employee: 20.09B
• Employees: 39
• Market Cap: 126.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	804.04B	11.08B	1.40%
Dec 31, 2022	792.96B	30.40B	3.99%
Dec 31, 2021	762.57B	571.30M	0.07%
Dec 31, 2020	762.00B	30.19B	4.13%
Dec 31, 2019	731.80B	589.07B	412.70%